Evexia Lifecare Ltd Stock Price Today (NSE: EVEXIA)
Fundamental Score
Evexia Lifecare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Evexia Lifecare Ltd share price today is ₹1.70, down 2.86% on NSE/BSE as of 17 June 2026. Evexia Lifecare Ltd (EVEXIA) is a Small-cap company in the Trading - Chemicals sector with a market capitalisation of ₹332.28 (Cr). The 52-week high for EVEXIA share price is ₹2.69 and the 52-week low is ₹0.47. At a P/E ratio of 232.37x, EVEXIA is currently trading above its industry average P/E of 65.53x. The company has a Return on Equity (ROE) of 0.32% and a debt-to-equity ratio of 2.16.
Evexia Lifecare Ltd Share Price Chart — NSE/BSE Historical Performance
Evexia Lifecare Ltd share price chart: 88.52% return over the past month. 52-week high ₹2.69, 52-week low ₹0.47.
Evexia Lifecare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1.22 | ₹1.22 | ₹1.15 | ₹1.15 | 32.46L (Cr) | |
| ₹1.25 | ₹1.28 | ₹1.16 | ₹1.21 | 108.30L (Cr) | |
| ₹1.22 | ₹1.22 | ₹1.12 | ₹1.22 | 225.51L (Cr) | |
| ₹1.17 | ₹1.17 | ₹1.17 | ₹1.17 | 9.28L (Cr) | |
| ₹1.12 | ₹1.12 | ₹1.12 | ₹1.12 | 20.18L (Cr) | |
| ₹1.07 | ₹1.07 | ₹1.07 | ₹1.07 | 11.46L (Cr) | |
| ₹1.02 | ₹1.02 | ₹1.01 | ₹1.02 | 130.68L (Cr) | |
| ₹0.98 | ₹0.98 | ₹0.95 | ₹0.98 | 289.80L (Cr) | |
| ₹0.94 | ₹0.94 | ₹0.94 | ₹0.94 | 7.14L (Cr) | |
| ₹0.90 | ₹0.90 | ₹0.90 | ₹0.90 | 8.50L (Cr) |
Evexia Lifecare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1.07 | ₹1.28 | ₹1.07 | ₹1.15 | +7.48% | |
| ₹0.51 | ₹1.02 | ₹0.47 | ₹1.02 | +100.00% | |
| ₹1.48 | ₹1.65 | ₹0.53 | ₹0.53 | -64.19% | |
| ₹1.63 | ₹1.90 | ₹1.48 | ₹1.50 | -7.98% | |
| ₹1.64 | ₹1.80 | ₹1.56 | ₹1.62 | -1.22% | |
| ₹1.70 | ₹1.95 | ₹1.53 | ₹1.64 | -3.53% | |
| ₹1.82 | ₹1.85 | ₹1.52 | ₹1.67 | -8.24% | |
| ₹2.05 | ₹2.15 | ₹1.65 | ₹1.80 | -12.20% | |
| ₹2.26 | ₹2.38 | ₹2.05 | ₹2.05 | -9.29% | |
| ₹2.27 | ₹2.42 | ₹2.20 | ₹2.26 | -0.44% | |
| ₹2.58 | ₹2.64 | ₹2.10 | ₹2.30 | -10.85% | |
| ₹2.39 | ₹2.69 | ₹2.29 | ₹2.58 | +7.95% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Evexia Lifecare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Evexia Lifecare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EVEXIA across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Strong Interest Coverage (5.69x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
12 factors identified
Below-Average Return on Equity (0.32%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.30%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-15.09%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 232.37x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-60.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Growth History (1.97% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-38.44% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-23.15% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Elevated Debt Levels (D/E: 2.16)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Low Promoter Commitment (3.36%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 0.56%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Evexia Lifecare Ltd vs Trading - Chemicals Peers
Peer Comparison - Trading - Chemicals
Compare Evexia Lifecare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Evexia Lifecare LtdEvexia Lifecare...Selected✓ EVEXIA • 524444 | 0/100 | ₹1.70₹2 | ₹332.28₹332.28 | 232.37Average 232.4 Average | 0.32%Poor 0.32% Poor | 0.30%Poor 0.30% Poor | 2.16Poor 2.2 Poor | -23.15%Poor -23.15% Poor | 1.97%Average 1.97% Average | 0.00% |
A 1A 1... AIL • 542012 | 25.9/100 | ₹44.10₹44 | ₹3077.11₹3077.11 | 1225.94Average 1225.9 Average | 7.82%Poor 7.82% Poor | 10.63%Average 10.63% Average | 0.35Excellent 0.3 Excellent | 3.75%Average 3.75% Average | 23.45%Excellent 23.45% Excellent | 0.06% |
Uniphos Enterprises LtdUniphos Enterpr... UNIENTER • 500429 | 36.1/100 | ₹106.52₹107 | ₹976.12₹976.12 | 51.43Average 51.4 Average | 0.01%Poor 0.01% Poor | 0.06%Poor 0.06% Poor | 0.00Excellent 0.0 Excellent | -57.73%Poor -57.73% Poor | 244.44%Excellent 244.44% Excellent | 0.35% |
Vinyl Chemicals India LtdVinyl Chemicals... VINYLINDIA • 524129 | 59.6/100 | ₹264.10₹264 | ₹451.64₹451.64 | 23.03Average 23.0 Average | 15.57%Good 15.57% Good | 21.12%Excellent 21.12% Excellent | 0.00Excellent 0.0 Excellent | 24.13%Excellent 24.13% Excellent | 10.92%Good 10.92% Good | 2.82% |
59.8/100 | ₹40.86₹41 | ₹430.15₹430.15 | 35.88Average 35.9 Average | 10.94%Average 10.94% Average | 14.08%Average 14.08% Average | 0.15Excellent 0.1 Excellent | 33.46%Excellent 33.46% Excellent | 24.82%Excellent 24.82% Excellent | 0.07% | |
Shiv Texchem LtdShiv Texchem Lt... SHIVTEXCHEM • 544272 | 42.5/100 | ₹156.05₹156 | ₹405.51₹405.51 | 5.76Average 5.8 Average | 18.30%Good 18.30% Good | 14.46%Average 14.46% Average | 1.15Average 1.1 Average | — — | — — | 0.00% |
27.7/100 | ₹31.15₹31 | ₹315.31₹315.31 | 79.62Average 79.6 Average | 16.42%Good 16.42% Good | 18.53%Good 18.53% Good | 0.37Excellent 0.4 Excellent | — — | — — | 0.00% | |
Yash Chemex LtdYash Chemex Ltd... YASHCHEM • 539939 | 34.7/100 | ₹53.87₹54 | ₹94.46₹94.46 | 53.67Average 53.7 Average | 5.60%Poor 5.60% Poor | 8.13%Poor 8.13% Poor | 0.35Excellent 0.3 Excellent | -2.94%Poor -2.94% Poor | 3.96%Average 3.96% Average | 0.00% |
Mysore Petro Chemicals LtdMysore Petro Ch... MYSORPETRO • 506734 | 35/100 | ₹102.00₹102 | ₹67.88₹67.88 | 8.22Average 8.2 Average | 1.30%Poor 1.30% Poor | 7.82%Poor 7.82% Poor | 0.00Excellent 0.0 Excellent | -8.99%Poor -8.99% Poor | 20.87%Excellent 20.87% Excellent | 1.94% |
Laffans Petrochemicals LtdLaffans Petroch... LAFFANSQ • 524522 | 19.6/100 | ₹27.28₹27 | ₹26.92₹26.92 | — — | 1.69%Poor 1.69% Poor | 2.30%Poor 2.30% Poor | 0.01Excellent 0.0 Excellent | 17.45%Excellent 17.45% Excellent | -7.70%Poor -7.70% Poor | 0.00% |
Citichem India LtdCitichem India ... CITICHEM • 544324 | 54.6/100 | ₹18.00₹18 | ₹17.34₹17.34 | 9.69Average 9.7 Average | 8.91%Poor 8.91% Poor | 11.56%Average 11.56% Average | 0.34Excellent 0.3 Excellent | 43.81%Excellent 43.81% Excellent | -15.65%Poor -15.65% Poor | 0.00% |
Top Trading - Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- A 1 share price3077.11 Cr
- Uniphos Enterprises Ltd share price976.12 Cr
- Vinyl Chemicals India Ltd share price451.64 Cr
- Shankar Lal Rampal Dye Chem Ltd share price430.15 Cr
- Shiv Texchem Ltd share price405.51 Cr
Evexia Lifecare Ltd PE Ratio History
Historical price-to-earnings ratio for EVEXIA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.02 | ₹3.45 | 172.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Evexia Lifecare Ltd Quarterly Performance
Latest quarterly metrics for EVEXIA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-3.67%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-60.64%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
1.97%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-23.15%
Compounded annual net profit growth over 5 years
Evexia Lifecare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for EVEXIA — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Evexia Lifecare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Evexia Lifecare Ltd (EVEXIA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Evexia Lifecare Ltd
About EVEXIA (Evexia Lifecare Ltd)
Evexia Lifecare Ltd is a multifaceted entity operating within the dynamic landscape of chemical trading. Sourcing and distributing a diverse portfolio of chemical products, Evexia ...caters to a broad spectrum of industries, positioning itself as a key intermediary in the supply chain. Beyond basic chemical compounds, the company's inventory includes specialized chemicals tailored for pharmaceutical applications, demonstrating a commitment to serving critical sectors with high-quality materials. Evexia's operations are geared toward facilitating the efficient flow of essential chemicals, supporting manufacturing processes and contributing to the broader economic ecosystem through its trading activities. The company aims to provide reliable access to chemicals, addressing the nuanced needs of its clientele and fostering long-term partnerships based on trust and performance. The scope of Evexia Lifecare's commercial activities extends beyond the realm of chemicals, encompassing a range of products. This diversification strategically broadens the company's market presence and reduces its reliance on specific sectors. These include edible oils, which addresses essential food and beverage sector needs. The trade of diamonds and gold suggests a presence in the commodity and potentially the luxury goods markets, adding another dimension to Evexia's portfolio. Furthermore, the inclusion of plastic granules and lubricants illustrates a focus on providing raw materials for manufacturing and industrial applications, strengthening the company's connection to the production of various goods. Evexia's approach demonstrates an adaptable strategy of capturing opportunities across different markets. In addition to its chemical trading and diversified product portfolio, Evexia Lifecare engages in technology-driven services, including website, mobile application, and software development, offering a unique synergistic approach. This indicates a strategy to integrate technology into its core operations and possibly offer solutions to clients. The company also entered into the manufacturing of eBikes, demonstrating a commitment to sustainable transportation. This expansion shows a broader vision that incorporates technology and sustainable solutions, potentially leveraging these segments to enhance the overall value proposition. Through its diverse activities, Evexia Lifecare aims to establish itself as a comprehensive player in multiple domains, combining traditional trading with modern technological advancements.
Company Details
Key Leadership
Latest News
EVEXIA Share Price: Frequently Asked Questions
What is the current share price of Evexia Lifecare Ltd?
Evexia Lifecare Ltd (EVEXIA) trades at ₹1.70 on NSE and BSE. Market cap ₹332.28 (Cr). Educational data only.
What is the P/E ratio of Evexia Lifecare Ltd?
Evexia Lifecare Ltd has a P/E of 232.37x vs industry average 65.53x.
What is the Bull Run score for Evexia Lifecare Ltd?
Evexia Lifecare Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Evexia Lifecare Ltd pay dividends?
Evexia Lifecare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Evexia Lifecare Ltd?
Evexia Lifecare Ltd has ROE of 0.32%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Evexia Lifecare Ltd?
Evexia Lifecare Ltd has debt-to-equity of 2.16.
Is Evexia Lifecare Ltd a good investment?
Bull Run gives Evexia Lifecare Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.